METHOTREXATE IN SARCOIDOSIS
Authors: PETER B. BARLOW
Journal: Annals of Internal Medicine (1969)

Letters and Comments1 November 1969METHOTREXATE IN SARCOIDOSISPETER B. BARLOW, M.D.PETER B. BARLOW, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-71-5-1028 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editor:I was disturbed to read the recent article by Dr. Mortimer Lacher (Spontaneous Remission or Response of Sarcoidosis to Methotrexate,Ann. Intern, Med. 69: 1247, 1968). Sarcoidosis is a disease of unknown etiology and may more properly be considered a syndrome. Whether a disease or syndrome, there are many specific granulomatous agents that may produce a very similar picture, and there are other illnesses with which sarcoidosis can be confused. Consequently, one should be very cautious as to which patients he labels with the diagnosis of sarcoidosis. Some criteria have been established for the diagnosis (Acta Med....References1. ROENIGKFOWLER-BERGFELDCURTIS HHWGH: Methotrexate for psoriasis in weekly oral doses. Arch. Derm. (Chicago) 99: 86, 1969. CrossrefMedlineGoogle Scholar2. BERLINRALLMEADFREIREICHVON SCOTTHERTZLIPSETT NIDJAEJERMB: Folic acid antagonists: effects on the cell and the patient. Ann. Intern. Med. 59: 931, 1963. LinkGoogle Scholar3. COEBULL ROFE: Cirrhosis associated with methotrexate treatment of psoriasis. JAMA 206: 1515, 1968. CrossrefMedlineGoogle Scholar4. RYANBODDINGTONSPRIGGS TJMMAI: Chromosomal abnormalities produced by folic acid antagonists. Brit. J. Derm. 77: 541, 1965. CrossrefMedlineGoogle Scholar1. ISRAEL HL: The diagnosis of sarcoidosis. Ann. Intern. Med. 68: 1323, 1968. LinkGoogle Scholar2. SCADDING JG: Sarcoidosis. Eyre and Spottiswoode, London, 1967. Google Scholar3. Proceedings of the Third International Conference on Sarcoidosis. Acta Med. Scand. 176 (suppl. 425): 287, 1964. MedlineGoogle Scholar4. LONGSCOPEFREIMAN WTDG: A study of sarcoidosis. Medicine (Balt.) 31: 1, 1952. CrossrefMedlineGoogle Scholar5. LACHER MJ: Long survival in Hodgkin's disease. Ann. Intern. Med. 70: 7, 1969. LinkGoogle Scholar6. REESBENNETTMAIBACHARNOLD RBJHHIHL: Methotrexate for psoriasis. Arch. Derm. (Chicago) 95: 2, 1967. CrossrefMedlineGoogle Scholar7. ROENIGKFOWLER-BERGFELDCURTIS HHWGH: Methotrexate for psoriasis in weekly oral doses. Arch. Derm. (Chicago) 99: 86, 1969. CrossrefMedlineGoogle Scholar8. CALLAWAYMCAFEEFINLAYSON JLWCRG: Management of psoriasis using methotrexate orally in a single weekly dose. Southern Med. J. 59: 424, 1966. CrossrefMedlineGoogle Scholar9. VAN SCOTT EJ: Discussion, in Rees and associates (reference 1). Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: PETER B. BARLOW, M.D.Affiliations: Medical Chest Section University Hospital Ann Arbor, Mich. 48104 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPulmonary Effects of Low-Dose Methotrexate Therapy 1 November 1969Volume 71, Issue 5_Part_1Page: 1028-1030KeywordsEtiologyMethotrexateSarcoidosis ePublished: 1 December 2008 Issue Published: 1 November 1969 PDF downloadLoading ...